ResMed (RMD) Tops Q4 EPS by 7c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $210.98 +1.16%
EPS Growth %: +13.3%
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
HFBL, PBHC, PBNK, More
EPS Growth %: +13.3%
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
HFBL, PBHC, PBNK, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $2.55, $0.07 better than the analyst estimate of $2.48. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.33 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regency Centers (REG) Tops Q2 EPS by 2c
- ITC Ltd. (ITC:IN) PT Lowered to INR310 at JPMorgan
- ABB India (ABB:IN) PT Raised to INR6,751 at JPMorgan
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
